Time-dependent protective and harmful effects of quercetin on 6-OHDA-induced toxicity in neuronal SH-SY5Y cells

Toxicology

Volumn 250, Issue 1, 2008, Pages 1-8

  Ossola, Bernardino ^a   Kääriäinen, Tiina M ^b   Raasmaja, Atso ^a   Männistö, Pekka T ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

6 Hydroxydopamine; Caspase 3; Neuroprotection; Parkinson's disease; Quercetin; SH SY5Y cells; Toxicity

Indexed keywords

OXIDOPAMINE; QUERCETIN;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; HUMAN; HUMAN CELL; IN VIVO STUDY; NERVE CELL; NERVE DEGENERATION; PARKINSON DISEASE; PRIORITY JOURNAL; SINGLE DRUG DOSE;

ANIMALS; ANTIOXIDANTS; CASPASE 3; CELL LINE, TUMOR; CELL SURVIVAL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; L-LACTATE DEHYDROGENASE; MALE; NEUROBLASTOMA; OXIDOPAMINE; PARKINSON DISEASE; QUERCETIN; RATS; RATS, WISTAR; TIME FACTORS;

RATTUS;

EID: 47849085831     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2008.04.001     Document Type: Article

References (46)

1. Angeloni C., Spencer J.P., Leoncini E., Biagi P.L., and Hrelia S. Role of quercetin and its in vivo metabolites in protecting H9c2 cells against oxidative stress. Biochimie 89 (2007) 73-82
2. Boots A.W., Kubben N., Haenen G.R., and Bast A. Oxidized quercetin reacts with thiols rather than with ascorbate: implication for quercetin supplementation. Biochem. Biophys. Res. Commun. 308 (2003) 560-565
3. Boots A.W., Li H., Schins R.P., Duffin R., Heemskerk J.W., Bast A., and Haenen G.R. The quercetin paradox. Toxicol. Appl. Pharmacol. 222 (2007) 89-96
4. Chen T.J., Jeng J.Y., Lin C.W., Wu C.Y., and Chen Y.C. Quercetin inhibition of ROS-dependent and -independent apoptosis in rat glioma C6 cells. Toxicology 223 (2006) 113-126
5. Csokay B., Prajda N., Weber G., and Olah E. Molecular mechanisms in the antiproliferative action of quercetin. Life Sci. 60 (1997) 2157-2163
6. Dajas F., Costa G., Abin-Carriquiry J.A., Echeverry C., Martinez-Borges A., and Dajas-Bailador F. Antioxidant and cholinergic neuroprotective mechanisms in experimental parkinsonism. Funct. Neurol. 17 (2002) 37-44
7. Dajas F., Rivera F., Blasina F., Arredondo F., Echeverry C., Lafon L., Morquio A., and Heizen H. Cell culture protection and in vivo neuroprotective capacity of flavonoids. Neurotox. Res. 5 (2003) 425-432
8. de Boer V.C., de Goffau M.C., Arts I.C., Hollman P.C., and Keijer J. SIRT1 stimulation by polyphenols is affected by their stability and metabolism. Mech. Ageing Dev. 127 (2006) 618-627
9. Dechsupa S., Kothan S., Vergote J., Leger G., Martineau A., Berangeo S., Kosanlavit R., Moretti J.L., and Mankhetkorn S. Quercetin, Siamois 1 and Siamois 2 induce apoptosis in human breast cancer MDA-mB-435 cells xenograft in vivo. Cancer Biol. Ther. 6 (2007) 56-61
10. Fahn S., and Cohen G. The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann. Neurol. 32 (1992) 804-812
11. Ferraresi R., Troiano L., Roat E., Lugli E., Nemes E., Nasi M., Pinti M., Fernandez M.I., Cooper E.L., and Cossarizza A. Essential requirement of reduced glutathione (GSH) for the anti-oxidant effect of the flavonoid quercetin. Free Radic. Res. 39 (2005) 1249-1258
12. Fotakis G., and Timbrell J.A. In vitro cytotoxicity assays: Comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride. Toxicol. Lett. 160 (2006) 171-177
13. Gagné B., Gélinas S., Bureau G., Lagacé B., Ramassamy C., Chiasson K., Valastro B., and Martinoli M.G. Effects of estradiol, phytoestrogens, and Ginkgo biloba extracts against 1-methyl-4-phenyl-pyridine-induced oxidative stress. Endocrine 21 (2003) 89-95
14. Gamet-Payrastre L., Manenti S., Gratacap M.P., Tulliez J., Chap H., and Payrastre B. Flavonoids and the inhibition of PKC and PI 3-kinase. Gen. Pharmacol. 32 (1999) 279-286
15. Gao Z., Huang K., and Xu H. Protective effects of flavonoids in the roots of Scutellaria baicalensis Georgi against hydrogen peroxide-induced oxidative stress in HS-SY5Y cells. Pharmacol. Res. 43 (2001) 173-178
16. Hanrott K., Gudmunsen L., O'Neill M.J., and Wonnacott S. 6-Hydroxydopamine-induced apoptosis is mediated via extracellular auto-oxidation and caspase 3-dependent activation of protein kinase Cdelta. J. Biol. Chem. 281 (2006) 5373-5382
17. Heo H.J., and Lee C.Y. Protective effects of quercetin and vitamin C against oxidative stress-induced neurodegeneration. J. Agric. Food Chem. 52 (2004) 7514-7517
18. Hosokawa N., Hirayoshi K., Nakai A., Hosokawa Y., Marui N., Yoshida M., Sakai T., Nishino H., Aoike A., and Kawai K. Flavonoids inhibit the expression of heat shock proteins. Cell Struct. Funct. 15 (1990) 393-401
19. Howitz K.T., Bitterman K.J., Cohen H.Y., Lamming D.W., Lavu S., Wood J.G., Zipkin R.E., Chung P., Kisielewski A., Zhang L.L., Scherer B., and Sinclair D.A. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425 (2003) 191-196
20. Huotari M., Kukkonen K., Liikka N., Potasev T., Raasmaja A., and Männistö P.T. Effects of histamine H(3)-ligands on the levodopa-induced turning behavior of hemiparkinsonian rats. Parkinsonism Relat. Disord. 6 (2000) 159-164
21. Ishikawa Y., and Kitamura M. Anti-apoptotic effect of quercetin: intervention in the JNK- and ERK-mediated apoptotic pathways. Kidney Int. 58 (2000) 1078-1087
22. Kääriäinen T., Piltonen M., Ossola B., Kekki H., Lehtonen S., Nenonen T., Lecklin A., Raasmaja A., and Männistö P.T. Lack of robust protective effect of quercetin in two types of 6-hydroxydopamine-induced parkinsonian models in rats and dopaminergic cell cultures. Brain Res. 1203 (2008) 149-159
23. Kuo S.M. Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cells. Cancer Lett. 110 (1996) 41-48
24. Lee D.C., Womble T.A., Mason C.W., Jackson I.M., Lamango N.S., Severs W.B., and Palm D.E. 6-Hydroxydopamine induces cystatin C-mediated cysteine protease suppression and cathepsin D activation. Neurochem. Int. 50 (2007) 607-618
25. Liu H., Nowak R., Chao W., and Bloch K.D. Nerve growth factor induces anti-apoptotic heme oxygenase-1 in rat pheochromocytoma PC12 cells. J. Neurochem. 86 (2003) 1553-1563
26. Liu Y., Peterson D.A., Kimura H., and Schubert D. Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. J. Neurochem. 69 (1997) 581-593
27. Mañáková S., Puttonen K.A., Raasmaja A., and Männistö P.T. Ara-C induces apoptosis in monkey fibroblast cells. Toxicol. In Vitro 17 (2003) 367-373
28. Mañáková S., Singh A., Kääriäinen T., Taari H., Kulkarni S.K., and Männistö P.T. Failure of FK506 (tacrolimus) to alleviate apomorphine-induced circling in rat Parkinson model in spite of some cytoprotective effects in SH-SY5Y dopaminergic cells. Brain Res. 1038 (2005) 83-91
29. Metodiewa D., Jaiswal A.K., Cenas N., Dickancaité E., and Segura-Aguilar J. Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal product. Free Radic. Biol. Med. 26 (1999) 107-116
30. Mira L., Fernandez M.T., Santos M., Rocha R., Florêncio M.H., and Jennings K.R. Interactions of flavonoids with iron and copper ions: a mechanism for their antioxidant activity. Free Radic. Res. 36 (2002) 1199-1208
31. Nair V.D. Activation of p53 signaling initiates apoptotic death in a cellular model of Parkinson's disease. Apoptosis 11 (2006) 955-966
32. Nylandsted J., Gyrd-Hansen M., Danielewicz A., Fehrenbacher N., Lademann U., Hoyer-Hansen M., Weber E., Multhoff G., Rohde M., and Jäättelä M. Heat shock protein 70 promotes cell survival by inhibiting lysosomal membrane permeabilization. J. Exp. Med. 200 (2004) 425-435
33. Okawara M., Katsuki H., Kurimoto E., Shibata H., Kume T., and Akaike A. Resveratrol protects dopaminergic neurons in midbrain slice culture from multiple insults. Biochem. Pharmacol. 73 (2007) 550-560
34. Pappolla M.A., Omar R.A., Kim K.S., and Robakis N.K. Immunohistochemical evidence of oxidative [corrected] stress in Alzheimer's disease. Am. J. Pathol. 140 (1992) 621-628
35. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1986), Academic press, New York
36. Ramos S. Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. J. Nutr. Biochem. 18 (2007) 427-442
37. Robaszkiewicz A., Balcerczyk A., and Bartosz G. Antioxidative and prooxidative effects of quercetin on A549 cells. Cell Biol. Int. 31 (2007) 1245-1250
38. Sasaki M., Nakamura H., Tsuchiya S., Horie S., Kashiwayanagi M., Saito T., and Murayama T. Quercetin-induced PC12 cell death accompanied by caspase-mediated DNA fragmentation. Biol. Pharm. Bull. 30 (2007) 682-686
39. Shimmyo, Y., Kihara, T., Akaike, A., Niidome, T., Sugimoto, H., in press. Three distinct neuroprotective functions of myricetin against glutamate-induced neuronal cell death: involvement of direct inhibition of caspase-3. J. Neurosci. Res.
40. Spencer J.P., Rice-Evans C., and Williams R.J. Modulation of pro-survival Akt/protein kinase B and ERK1/2 signaling cascades by quercetin and its in vivo metabolites underlie their action on neuronal viability. J. Biol. Chem. 278 (2003) 34783-34793
41. Supino R. MTT assays. Methods Mol. Biol. 43 (1995) 137-149
42. Vaziri H., Dessain S.K., Ng Eaton E., Imai S.I., Frye R.A., Pandita T.K., Guarente L., and Weinberg R.A. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107 (2001) 149-159
43. Vlahos C.J., Matter W.F., Hui K.Y., and Brown R.F. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269 (1994) 5241-5248
44. Walkinshaw G., and Waters C.M. Neurotoxin-induced cell death in neuronal PC12 cells is mediated by induction of apoptosis. Neuroscience 63 (1994) 975-987
45. Wei Y.Q., Zhao X., Kariya Y., Fukata H., Teshigawara K., and Uchida A. Induction of apoptosis by quercetin: involvement of heat shock protein. Cancer Res. 54 (1994) 4952-4957
46. Zbarsky V., Datla K.P., Parkar S., Rai D.K., Aruoma O.I., and Dexter D.T. Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease. Free Radic. Res. 39 (2005) 1119-1125